The DOI matches its Crossref record; 183 of the 186 references it cites were found in a registry or an index.
Nicotinic receptors in human brain: topography and pathology
Open accessAbstract
Brain nicotinic acetylcholine receptors (nAChR) are a class of ligand-gated channels composed of alpha and beta subunits with specific structural, functional and pharmacological properties. They participate in the physiological and behavioural effects of acetylcholine and mediate responses to nicotine. They are associated with numerous transmitter systems and their expression is altered during development and ageing as well as in diseases such as autism, schizophrenia, Alzheimer's disease, Parkinson's disease and Lewy body dementia. Nicotinic receptors containing a number of different subunits are highly expressed during early human development. Disorders believed to be associated with abnormal brain maturation involve deficits in both alpha4beta2, in the case of autism, and alpha7 possibly in addition to alpha4beta2 nAChRs in the case of schizophrenia. In ageing and age-related neurodegenerative disorders nAChR deficits are predominantly associated with alpha4-containing receptors, although some studies also indicate the involvement of alpha3 and alpha7 subunits. Whilst ageing appears to be associated with reductions in subunit mRNA as well as protein expression, in Alzheimer's disease only protein loss is apparent. Nicotinic therapy may be of benefit in a number of neurological conditions, however studies evaluating further both the distribution of specific subunit involvement and the correlation of nAChR deficits with clinical symptoms are required to inform therapeutic strategy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The heteromeric a4b2* subtype and the homomeric a7 are the most prevalent receptor subtypes in the central nervous system (Court et al., 2000).”
From Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors (2014) · cites this paper as Court et al., 2000
Citations
Cites
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Self-citationSELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
A rapid radiochemical method for the determination of choline acetyltransferase
Fonnum, F. (1975) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1975.tb11895.x · Cited by 2,358
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,293
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141
Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
McGehee, D. S., Heath, M. J. S., Gelber, S., Devay, P., & Role, L. W. (1995) · Science · doi:10.1126/science.7569895 · Cited by 1,070
Physiological Diversity of Nicotinic Acetylcholine Receptors Expressed by Vertebrate Neurons
McGehee, D. S., & Role, L. W. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.002513 · Cited by 1,022
Frith, U., & Mira, M. P. (1992) · Focus on Autism and Other Developmental Disabilities · doi:10.1177/108835769200700302 · Cited by 900
Nitsch, R. M., Slack, B. E., Wurtman, R. J., & Growdon, J. H. (1992) · Science · doi:10.1126/science.1411529 · Cited by 898
Neuronal nicotinic receptors in the human brain
Paterson, D., & Nordberg, A. K. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00045-3 · Cited by 792
Nicotine activates and desensitizes midbrain dopamine neurons
Pidoplichko, V. I., DeBiasi, M., Williams, J. T., & Dani, J. A. (1997) · Nature · doi:10.1038/37120 · Cited by 769
Acetylcholine in mind: a neurotransmitter correlate of consciousness?
Perry, E. K., Walker, M. P., Grace, J., & Perry, R. H. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01361-7 · Cited by 764
Self-citationSchizophrenia, sensory gating, and nicotinic receptors
Adler, L. E., Olincy, A., Waldo, M., Harris, J. G., Griffith, J., Stevens, K., Flach, K., Nagamoto, H., Bickford, P., Leonard, S., et al. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033320 · Cited by 690
Neuroleptic sensitivity in patients with senile dementia of Lewy body type.
McKeith, I., Fairbairn, A., Perry, R., Thompson, P. M., & Perry, E. (1992) · British medical journal · doi:10.1136/bmj.305.6855.673 · Cited by 687
Self-citationNormalization of auditory physiology by cigarette smoking in schizophrenic patients
Adler, L. E., Hoffer, L., Wiser, A., & Freedman, R. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1856 · Cited by 679
Freedman, R., Hall, M., Adler, L. E., & Leonard, S. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00252-x · Cited by 678
Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain
Picciotto, M. R., Zoli, M., Léna, C., Bessis, A., Lallemand, Y., LeNovère, N., Vincent, P., Pich, E. M., Brûlet, P., & Changeux, J.-P. (1995) · Nature · doi:10.1038/374065a0 · Cited by 668
Environmental risk factors and Parkinson's disease
Liou, H., Tsai, M.-C., Chen, C., Jeng, J., Chang, Y. C., Chen, S. Y., & Chen, R.-T. (1997) · Neurology · doi:10.1212/wnl.48.6.1583 · Cited by 616
Senile dementia of Lewy body type
Perry, R. H., Irving, D., Blessed, G., FAIRBAIRN, A. F., & Perry, E. K. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90236-g · Cited by 575
Self-citationReduced antinociception in mice lacking neuronal nicotinic receptor subunits
Marubio, L. M., Jiménez, M. D. M. A., Cordero‐Erausquin, M., Léna, C., Novère, N. G. L., d’Exaerde, A. D. K., Huchet, M., Damaj, M. I., & Changeux, J. (1999) · Nature · doi:10.1038/19756 · Cited by 538
Alkondon, M., & Albuquerque, E. X. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38283-2 · Cited by 538
Jones, G., Sahakian, B. J., Levy, R., Warburton, D. M., & Gray, J. A. (1992) · Psychopharmacology · doi:10.1007/bf02247426 · Cited by 476
Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors
Vernino, S. A., Amador, M., Luetje, C. W., Patrick, J., & Dani, J. A. (1992) · Neuron · doi:10.1016/0896-6273(92)90114-s · Cited by 463
Human neuronal nicotinic receptors
Gotti, C., Fornasari, D., & Clementi, F. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00034-8 · Cited by 417
The cerebral cortex of the rat
(1991) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(91)90172-9 · Cited by 416
Plaisted, K., Swettenham, J., & Rees, L. (1999) · Journal of Child Psychology and Psychiatry · doi:10.1111/1469-7610.00489 · Cited by 409
Identification of Four Classes of Brain Nicotinic Receptors Using β2 Mutant Mice
Zoli, M., Léna, C., Picciotto, M. R., & Changeux, J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04461.1998 · Cited by 404
Eisenberg, L. (1992) · The Lancet · doi:10.1016/0140-6736(92)90257-4 · Cited by 401
Cholinergic Activity in Autism: Abnormalities in the Cerebral Cortex and Basal Forebrain
Perry, E. K., Lee, M., Martin-Ruiz, C. M., COURT, J. A., Volsen, S. G., Merrit, J., Folly, E. A., Iversen, P. E., Bauman, M. L., Perry, R. H., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1058 · Cited by 390
Self-citationIdentification of four classes of brain nicotinic receptors using beta2 mutant mice.
Zoli, M., Léna, C., Picciotto, M. R., & Changeux, J. (1998) · PubMed Central · doi:10.1523/jneurosci.18-12-04461.1996 · Cited by 387
Perry, E. K., Morris, C. M., COURT, J. A., Cheng, A. V., FAIRBAIRN, A. F., McKeith, I. G., Irving, D., Brown, A. J., & Perry, R. H. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00410-7 · Cited by 386
Self-citationLe Novere, N., Zoli, M., & Changeux, J. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01206.x · Cited by 385
Cigarette smoking and protection from Parkinson's disease
Morens, D. M., Grandinetti, A., REED, D. M., White, L. R., & Ross, G. W. (1995) · Neurology · doi:10.1212/wnl.45.6.1041 · Cited by 368
Bannon, A. W., Decker, M. W., Holladay, M. W., Curzon, P., Donnelly‐Roberts, D. L., Puttfarcken, P. S., Bitner, R. S., Díaz, Á., Dickenson, A. H., Porsolt, R. D., et al. (1998) · Science · doi:10.1126/science.279.5347.77 · Cited by 368
Jellinger, K. A. (1999) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6360-3_1 · Cited by 359
The paradox of nicotinic acetylcholine receptor upregulation by nicotine
Wonnacott, S. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90242-z · Cited by 357
Mulle, C., Choquet, D., Korn, H., & Changeux, J. (1992) · Neuron · doi:10.1016/0896-6273(92)90115-t · Cited by 351
Assembly of Human Neuronal Nicotinic Receptor α5 Subunits with α3, β2, and β4 Subunits
Wang, F., Gerzanich, V., Wells, G. B., Anand, R., Peng, X.-D., Keyser, K. T., & Lindstrom, J. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17656 · Cited by 345
Lohr, J. B., & FLYNN, K. (1992) · Schizophrenia Research · doi:10.1016/0920-9964(92)90024-y · Cited by 339
Cholinergic dysfunction in diseases with Lewy bodies
Tiraboschi, P., Hansen, L. A., Alford, M. F., Sabbagh, M. N., Schoos, B., Masliah, E., Thal, L. J., & Corey‐Bloom, J. (2000) · Neurology · doi:10.1212/wnl.54.2.407 · Cited by 332
Fenster, C. P., Rains, M. F., Noerager, B., Quick, M. W., & Lester, R. A. J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05747.1997 · Cited by 332
Piggott, M. A., Marshall, E. F., Thomas, N., Lloyd, S. R., COURT, J. A., Jaros, E., Burn, D. J., Johnson, M. K., Perry, R. H., McKeith, I. G., et al. (1999) · Brain · doi:10.1093/brain/122.8.1449 · Cited by 327
Self-citationRapin, I. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370206 · Cited by 319
Aubert, I., Araujo, D. M., Cécyre, D., Robitaille, Y., Gauthier, S. G., & Quirion, R. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09752.x · Cited by 317
Picchietti, D. L., Underwood, D. J., Farris, W. A., Walters, A. S., Shah, M., Dahl, R. E., Trubnick, L. J., Bertocci, M. A., Wagner, M., & Hening, W. A. (1999) · Movement Disorders · doi:10.1002/1531-8257(199911)14:6 · Cited by 290
Guan, Z., Zhang, X., Ravid, R., & Nordberg, A. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740237.x · Cited by 289
Marshall, D. L., Redfern, P. H., & Wonnacott, S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68041511.x · Cited by 284
Flynn, D. D., & Mash, D. C. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb13113.x · Cited by 284
Clarke, P. B. S., & Reuben, M. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15232.x · Cited by 262
Changes in Nicotinic and Muscarinic Cholinergic Receptors in Alzheimer‐Type Dementia
Shimohama, S., Taniguchi, T., Fujiwara, M., & Kameyama, M. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb12960.x · Cited by 258
Neuronal Nicotinic Receptors in Dementia with Lewy Bodies and Schizophrenia
COURT, J. A., Spurden, D., Lloyd, S. R., McKeith, I. G., Ballard, C. G., Cairns, N. J., Kerwin, R. W., Perry, R., & Perry, E. K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731590.x · Cited by 252
Self-citationNicotinic receptor abnormalities in Alzheimer’s disease
COURT, J. A., Martin-Ruiz, C. M., Piggott, M. A., Spurden, D., Griffiths, M., & Perry, E. K. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01116-1 · Cited by 232
Self-citationBreese, C. R., Adams, C. E., Logel, J., Drebing, C. J., Rollins, Y. D., Barnhart, M. M., Sullivan, B. F., DeMasters, B. K., Freedman, R., & Leonard, S. S. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971027)387:3 · Cited by 231
Trauth, J. A., Seidler, F. J., McCook, E. C., & Slotkin, T. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01994-0 · Cited by 230
Methyllycaconitine: a selective probe for neuronal α‐bungarotoxin binding sites
Ward, J. M., Cockcroft, V. B., Lunt, G. G., Smillie, F., & Wonnacott, S. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81231-c · Cited by 223
Prospective Study of Cigarette Smoking and the Risk of Developing Idiopathic Parkinson's Disease
Grandinetti, A., Morens, D. M., REED, D. M., & MacEachern, D. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116960 · Cited by 221
Neurofunctional mechanisms in autism
Waterhouse, L., Fein, D., & Modahl, C. (1996) · Psychological Review · doi:10.1037/0033-295x.103.3.457 · Cited by 218
Palma, E., Bertrand, S., Binzoni, T., & Bertrand, D. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021203 · Cited by 218
Bauman, M. L. (2006) · Johns Hopkins University Press eBooks · doi:10.1353/book.3225 · Cited by 215
Hellström‐Lindahl, E., Mousavi, M. T., Zhang, X., Ravid, R., & Nordberg, A. K. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00030-3 · Cited by 215
Cholinergic Transmitter and Neurotrophic Activities in Lewy Body Dementia
Perry, E. K., Irving, D., Kerwin, J. M., McKeith, I. G., Thompson, P., Collerton, D., FAIRBAIRN, A. F., Ince, P. G., Morris, C. M., Cheng, A. V., et al. (1993) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199307020-00002 · Cited by 213
Self-citationNordberg, A. K., Lundqvist, H., Hartvig, P., Lilja, A., & Långström, B. (1995) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199505000-00006 · Cited by 212
[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy
Bokobza, B., Ruberg, M., Scatton, B., Javoy-Agid, F., & Agid, Y. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90238-3 · Cited by 209
Biological Aspects of Alzheimer's Disease
(1984) · Journal of Gerontology · doi:10.1093/geronj/39.5.630a · Cited by 203
Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases
Perry, E. K., Martin-Ruiz, C. M., Lee, M., Griffiths, M., Johnson, M., Piggott, M. A., Haroutunian, V. H., Buxbaum, J. D., Nãsland, J., Davis, K. L., et al. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00064-9 · Cited by 201
Self-citationA postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease
Rinne, J. O., ̈, T. M., Lönnberg, P., & Marjama¨ki, P. (1991) · Brain Research · doi:10.1016/0006-8993(91)90588-m · Cited by 195
Martin-Ruiz, C. M., COURT, J. A., Molnár, E., Lee, M., Gotti, C., Mamalaki, A., Tsouloufis, T., Tzartos, S. J., Ballard, C. G., Perry, R. H., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731635.x · Cited by 194
Self-citationDownregulation of nicotinic receptor function after chronic nicotine infusion.
Marks, M. J., Grady, S. R., & Collins, A. C. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39368-7 · Cited by 190
Burghaus, L., Schütz, U., Krempel, U., de Vos, R. A. I., Steur, E. N. H. J., Wevers, A., Lindstrom, J. M., & Schröder, H. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00031-0 · Cited by 178
Olale, F., Gerzanich, V., Kuryatov, A., Wang, F., & Lindstrom, J. M. (1997) · PubMed · Cited by 172
Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens
Damsma, G., Day, J. C., & Fibiger, H. C. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90798-x · Cited by 170
Benwell, M. E. M., Balfour, D. J. K., & Birrell, C. E. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb13248.x · Cited by 169
Charpantier, E., Barnéoud, P., Moser, P. C., Besnard, F., & Sgard, F. (1998) · Neuroreport · doi:10.1097/00001756-199809140-00033 · Cited by 166
Autism: recent molecular genetic advances
Lamb, J. A. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.6.861 · Cited by 164
Cholinergic regulation of cortical development and plasticity. New twists to an old story.
Cf, H., & Berger-Sweeney, J. E. (1998) · PubMed · Cited by 161
Neuroreceptor changes in Alzheimer disease.
Nordberg, A. K. (1992) · PubMed · Cited by 160
Neuronal Nicotinic Receptor Subtypes
Lindstrom, J. M., Anand, R., Peng, X.-D., Gerzanich, V., Wang, F., & LI, Y. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17467.x · Cited by 160
Wevers, A., Monteggia, L. M., Nowacki, S., Bloch, W., Schütz, U., Lindstrom, J. M., Pereira, E. F. R., Eisenberg, H. M., Giacobini, E., de Vos, R. A. I., et al. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00676.x · Cited by 159
Sensitization of the Mesoaccumbens Dopamine Response to Nicotine
Balfour, D. J. K., Benwell, M. E. M., Birrell, C. E., Kelly, J. T., & Al-Aloul, M. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00537-6 · Cited by 157
COURT, J. A., Piggott, M. A., Lloyd, S. R., Cookson, N., Ballard, C. G., McKeith, I. G., Perry, R. H., & Perry, E. K. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00071-3 · Cited by 156
Self-citationNicotine may relieve symptoms of Parkinson's disease
Fagerström, K. O., Pomerleau, O. F., Giordani, B., & Stelson, F. W. (1994) · Psychopharmacology · doi:10.1007/bf02244882 · Cited by 155
Michele, G. D., Filla, A., Volpe, G., Marco, V. D., Gogliettino, A., Ambrosio, G., Marconi, R., Castellano, A., & Campanella, G. (1996) · Movement Disorders · doi:10.1002/mds.870110105 · Cited by 149
Cholinergic Receptors in Cognitive Disorders
Perry, E. K., Perry, R. H., Smith, C. J., Purohit, D. P., Bonham, J. R., Dick, D. J., Candy, J., Edwardson, J. A., & FAIRBAIRN, A. F. (1986) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100037240 · Cited by 149
Self-citationNicotine psychopharmacology; molecular, cellular and behavioural aspects
Wonnacott, S. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90259-9 · Cited by 148
COURT, J. A., Lloyd, S. R., Johnson, M. H., Griffiths, M., Birdsall, N. J. M., Piggott, M. A., Oakley, A. E., Ince, P. G., Perry, E. K., & Perry, R. H. (1997) · Developmental Brain Research · doi:10.1016/s0165-3806(97)00052-7 · Cited by 146
Self-citationNicotinic acetylcholine receptor subtypes in human frontal cortex: Changes in Alzheimer's disease
Sugaya, K., Giacobini, E., & Chiappinelli, V. A. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270314 · Cited by 144
Flores, C. M., Dávila‐García, M. I., Ulrich‐Lai, Y. M., & Kellar, K. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052216.x · Cited by 142
Reductions in Acetylcholine and Nicotine Binding in Several Degenerative Diseases
Whitehouse, P. J., Martino, A. M., Marcus, K. A., Zweig, R. M., Singer, H. S., Price, D. L., & Kellar, K. J. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520310028012 · Cited by 141
Improvement in Smooth Pursuit Eye Movements after Cigarette Smoking in Schizophrenic Patients
D, A. O. M. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00095-x · Cited by 136
Ke, L., Eisenhour, C. M., Bencherif, M., & Lukas, R. J. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37658-x · Cited by 136
Court, J. A., Lloyd, S., Thomas, N., Piggott, M. A., Marshall, E. F., Morris, C. M., Lamb, H., Perry, R. H., Johnson, M., & Perry, E. K. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00088-8 · Cited by 135
Self-citationDistribution of Nicotinic Receptors in the Human Hippocampus and Thalamus
Rubboli, F., COURT, J. A., Sala, C., Morris, C. M., Chini, B., Perry, E. K., & Clementi, F. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00550.x · Cited by 134
Self-citationThe fall and rise of neuronal α-bungarotoxin binding proteins
Clarke, P. B. S. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90125-p · Cited by 133
A RETROSPECTIVE STUDY OF SMOKING IN PARKINSON'S DISEASE1
Nefzger, M. D., QUADFASEL, F. A., & KARL, V. C. (1968) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120874 · Cited by 130
Desensitization of Nicotine‐Stimulated [3H]Dopamine Release from Mouse Striatal Synaptosomes
Grady, S. R., Marks, M. J., & Collins, A. C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62041390.x · Cited by 126
Lange, K. W., Wells, F. R., Jenner, P. G., & MARSDEN, C. D. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05838.x · Cited by 125
Perry, E. K., Smith, C. J., COURT, J. A., & Perry, R. H. (1990) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02257646 · Cited by 124
Self-citationNicotine‐induced Protection Against Glutamate Cytotoxicity
Shimohama, S., AKAIKE, A., & Kimura, J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34445.x · Cited by 118
Effects of smoking in patients with early-onset Parkinson's disease
Ishikawa, A., & Miyatake, T. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90150-w · Cited by 115
Durany, N., Zöchling, R., Boissl, K. W., Paulus, W., Ransmayr, G. N., Tatschner, T., Danielczyk, W., Jellinger, K. A., Deckert, J., & Riederer, P. F. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01144-7 · Cited by 112
CNS Neurotransmitters and Neuromodulators: Dopamine
Stone, T. W. (1996) · Medical Entomology and Zoology · Cited by 106
Barrantes, G. E., Rogers, A. T., Lindstrom, J. M., & Wonnacott, S. (1995) · Brain Research · doi:10.1016/0006-8993(94)01386-v · Cited by 106
Nicotine for the treatment of Tourette's syndrome
Sanberg, P. R., Silver, A. A., Shytle, R. D., Philipp, M. K., Cahill, D. W., Fogelson, H. M., & McConville, B. J. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00199-4 · Cited by 106
Trouslard, J., Marsh, S. J., & Brown, D. A. (1993) · The Journal of Physiology · doi:10.1113/jphysiol.1993.sp019759 · Cited by 100
Chini, B., Raimond, E., Elgoyhen, A. B., Moralli, D., Balzaretti, M., & Heinemann, S. (1994) · Genomics · doi:10.1006/geno.1994.1075 · Cited by 99
Postmortem stability of α-bungarotoxin binding sites in mouse and human brain
Davies, P., & Feisullin, S. (1981) · Brain Research · doi:10.1016/0006-8993(81)90148-7 · Cited by 99
Marutle, A., Berglund, U. W., Bogdanović, N., & Nordberg, A. K. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00558-7 · Cited by 96
Decreases in protective enzymes correlates with increased oxidative damage in the aging mouse brain
Mo, J. Q., Hom, D. G., & Andersen, J. K. (1995) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(95)01586-o · Cited by 96
Mcconville, B. J., Sanberg, P. R., Fogelson, M. H., King, J., Cirino, P. T., Parker, K. W., & Norman, A. B. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90315-q · Cited by 94
Huppert, F. A., Brayne, C., & O’Connor, D. (1994) · Cambridge University Press eBooks · Cited by 93
Nicotinic acetylcholine receptors during prenatal development and brain pathology in human aging
Hellström‐Lindahl, E., & COURT, J. A. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00210-2 · Cited by 92
Self-citationRogers, S. W., Gahring, L. C., Collins, A. C., & Marks, M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04825.1998 · Cited by 91
Immunohisto- and cytochemical localization of cortical nicotinic cholinoceptors in rat and man
Schröder, H., Zilles, K., Maelicke, A., & Hajós, F. (1989) · Brain Research · doi:10.1016/0006-8993(89)90624-0 · Cited by 90
Yu, Z. J., & Wecker, L. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63010186.x · Cited by 90
THE ROLE OF THE NUCLEUS BASALIS OF MEYNERT IN DEMENTIA: REVIEW AND RECONSIDERATION
Cummnings, J. L., & Benson, D. F. (1987) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198701030-00003 · Cited by 88
Smoking and Parkinson's disease: a case-control study in Germany
Hellenbrand, W., Seidler, A., Robra, B., Vieregge, P., Oertel, W. H., Joerg, J., NISCHAN, P., Schneider, E., & Ulm, G. (1997) · International Journal of Epidemiology · doi:10.1093/ije/26.2.328 · Cited by 87
Hsu, Y., Αmin, J., Weiss, D. S., & Wecker, L. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66020667.x · Cited by 87
Morphological substrates of dementia in parkinsonism A critical update
Jellinger, K. A. (1997) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6846-2_6 · Cited by 85
Nicotine modulates the neurotoxic effect of β-amyloid protein(25–35) in hippocampal cultures
Zamani, R., Allen, Y. S., Owen, G. P., & Gray, J. A. (1997) · Neuroreport · doi:10.1097/00001756-199701200-00027 · Cited by 85
Kiba, H., & Jayaraman, A. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90205-4 · Cited by 84
Nitsch, R. M., Deng, A., Wurtman, R. J., & Growdon, J. H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69020704.x · Cited by 84
Evidence for Functional Activity of Up‐Regulated Nicotine Binding Sites in Rat Striatal Synaptosomes
Rowell, P. P., & Wonnacott, S. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb05802.x · Cited by 84
Nicotinic Acetylcholine Receptors in Alzheimer's Disease
Wevers, A., & Schröder, H. (1999) · Journal of Alzheimer s Disease · doi:10.3233/jad-1999-14-503 · Cited by 84
Belluardo, N., Blum, M., Mudò, G., Andbjer, B., & Fuxé, K. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00323-0 · Cited by 83
Spurden, D., COURT, J. A., Lloyd, S. R., Oakley, A. E., Perry, R., Pearson, C., Pullen, R. G. L., & Perry, E. K. (1997) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(97)00038-0 · Cited by 76
Self-citationMolinari, E. J., Delbono, O., Messi, M. L., Renganathan, M., Arnerić, S. P., Sullivan, J. P., & Gopalakrishnan, M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00084-3 · Cited by 75
Wevers, A., Jeske, A., Lobron, C., Birtsch, C., Heinemann, S., Maelicke, A., Schröder, R., & Schröder, H. C. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90286-0 · Cited by 72
Potential Role of Muscarinic Agonists in Alzheimerʼs Disease
Avery, E., Baker, L. D., & Asthana, S. (1997) · Drugs & Aging · doi:10.2165/00002512-199711060-00004 · Cited by 71
Rowell, P. P., & Hillebrand, J. A. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63020561.x · Cited by 70
Nicotine psychopharmacology; molecular, cellular and behavioural aspects
Wonnacott, S. (1991) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(91)90222-x · Cited by 68
Mattson, M. P. (1996) · PubMed · Cited by 67
Tordjman, S., Antoine, C., Cohen, D. J., Gauvain‐Piquard, A., Carlier, M., Roubertoux, P. L., & Ferrari, P. (1999) · PubMed · Cited by 65
Smoking and Parkinson's disease
Tzourio, C., Rocca, W. A., Breteler, M. M. B., Baldereschi, M., Dartigues, J.-F., Pousa, S. L., Manubens-Bertran, J. M., Alpérovitch, A., & the EUROPARKINSON Study Group (1997) · Neurology · doi:10.1212/wnl.49.5.1267 · Cited by 63
Falk, W. E. (1995) · Psychosomatics · doi:10.1016/s0033-3182(95)71617-6 · Cited by 61
Xuereb, J. H., Perry, E. K., Candy, J., Bonham, J. R., Perry, R. H., & Marshall, E. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90155-g · Cited by 61
Self-citationDesensitization of Nicotine‐Stimulated 86Rb+ Efflux from Mouse Brain Synaptosomes
Marks, M. J., Grady, S. R., Yang, J., Lippiello, P. M., & Collins, A. C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062125.x · Cited by 61
Apoptosis and Oxidative Stress in the Aging Brain
Adams, J. D., Jr., Mukherjee, S. K., Klaidman, L. K., CHANG, M. L., & Yasharel, R. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb39058.x · Cited by 60
Chen, Y., Ögren, S. O., Bjelke, B., Bolme, P., Eneroth, P. H. E., Gross, J. P., Loidl, F., Herrera‐Marschitz, M., & Anderssn, K. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00118-3 · Cited by 58
The Aging brain : cellular and molecular mechanisms of aging in the nervous system
Giacobini, E. (1982) · Raven Press eBooks · Cited by 57
Tohgi, H., Utsugisawa, K., Yoshimura, M., Nagane, Y., & Mihara, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00205-5 · Cited by 57
Variations of monoamines and their metabolites in the human brain putamen
Konradi, C. L., Kornhuber, J., Sofic, E., Heckers, S., Riederer, P. F., & Beckmann, H. (1992) · Brain Research · doi:10.1016/0006-8993(92)90062-e · Cited by 55
CNS Neurotransmitters and Neuromodulators
Stone, T. W. (2020) · CRC Press eBooks · doi:10.1201/9781003068723 · Cited by 54
Sihver, W., Gillberg, P.-G., Svensson, A., & Nordberg, A. K. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00295-x · Cited by 53
Expression of the α3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease
Terzano, S., Court, J. A., Fornasari, D., Griffiths, M., Spurden, D., Lloyd, S. R., Perry, R. H., Perry, E. K., & Clementi, F. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00260-5 · Cited by 51
Self-citationBrain Nicotinic and Muscarinic Receptors in Normal Aging and Dementia
Nordberg, A. K., & Winblad, B. G. (1986) · Advances in behavioral biology · doi:10.1007/978-1-4613-2179-8_12 · Cited by 48
Perry, E. K., COURT, J. A., Johnson, M., Piggott, M. A., & Perry, R. H. (1992) · Journal of Chemical Neuroanatomy · doi:10.1016/0891-0618(92)90056-v · Cited by 47
Self-citationDURSUN, S. M., & Reveley, M. A. (1997) · Psychological Medicine · doi:10.1017/s0033291796003984 · Cited by 46
Serum antibodies to nicotinic acetylcholine receptors in schizophrenic patients
Mukherjee, S., Mahadik, S. P., Korenovsky, A., Laev, H., Schnur, D. B., & Reddy, R. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90070-1 · Cited by 44
Kem, W. R. (1997) · Invertebrate Neuroscience · doi:10.1007/bf02480382 · Cited by 43
Martin-Ruiz, C. M., Piggott, M. A., Gotti, C., Lindstrom, J. M., Mendelow, A. D., Siddique, M. S., Perry, R. H., Perry, E. K., & COURT, J. A. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00110-6 · Cited by 43
Self-citationNeocortical Cholinergic Enzyme and Receptor Activities in the Human Fetal Brain
Perry, E. K., Smith, C. J., Atack, J. R., Candy, J. M., Johnson, M., & Perry, R. H. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb00749.x · Cited by 41
Self-citationAttenuation of β‐Amyloid Neurotoxicity In Vitro by Potassium‐Induced Depolarization
Pike, C. J., Balázs, R., & Cotman, C. W. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67041774.x · Cited by 41
Tönnes, J., Stierli, B., Cerletti, C., Behrmann, J. T., Molnár, E., & Streit, P. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.02195.x · Cited by 41
Gotti, C., Briscini, L., Verderio, C., Oortgiesen, M., Balestra, B., & Clementi, F. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00630.x · Cited by 39
Parks, R. W., Becker, R. E., Rippey, R. F., Gilbert, D. G., Matthews, J. R., Kabatay, E., Young, C. S., Vohs, C., Danz, V., Keim, P., et al. (1996) · Neuropsychology Review · doi:10.1007/bf01875368 · Cited by 39
Chronic nicotine intake decelerates aging of nigrostriatal dopaminergic neurons
Prasad, C., Ikegami, H., Shimizu, I., & Onaivi, E. S. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00839-6 · Cited by 39
Alzheimer’s and Parkinson’s Disease: Strategies in Research and Development
Hanin, I. (1986) · Advances in behavioral biology · doi:10.1007/978-1-4613-2179-8_75 · Cited by 39
Tohgi, H., Utsugisawa, K., Yoshimura, M., Nagane, Y., & Mihara, M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00093-6 · Cited by 37
Elliott, K. J., Jones, J. M., Sacaan, A. I., Lloyd, G. K., & Corey-Naeve, J. (1998) · Journal of Molecular Neuroscience · doi:10.1007/bf02761778 · Cited by 34
Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease
Sabbagh, M. N., Reid, R. T., Corey‐Bloom, J., Rao, T. S., Hansen, L. A., Alford, M. F., Masliah, E., Adem, A., Lloyd, G. K., & Thal, L. J. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050090 · Cited by 34
Janson, A. M., Fuxé, K., Agnati, L. F., Jansson, A., Bjelke, B., Sundström, E., Andersson, K., Härfstrand, A., Goldstein, M., & Owmand, C. (1989) · Progress in brain research · doi:10.1016/s0079-6123(08)62485-1 · Cited by 33
Muscarinic and nicotinic receptor changes in the cortex and thalamus of brains of chronic alcoholics
̈m-Lindahl, E. H., Winblad, B. G., & Nordberg, A. K. (1993) · Brain Research · doi:10.1016/0006-8993(93)90268-r · Cited by 32
COURT, J. A., Perry, E. K., Spurden, D., Lloyd, S. R., Gillespie, J., Whiting, P. J., & Barlow, R. B. (1994) · Brain Research · doi:10.1016/0006-8993(94)91721-3 · Cited by 31
Self-citationUtsugisawa, K., Nagane, Y., Tohgi, H., Yoshimura, M., Ohba, H., & Genda, Y. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00473-5 · Cited by 31
Localization of mRNA for CHRNA7 in human fetal brain.
Agulhon, C., Abitbol, M. M., Bertrand, D., & Malafosse, A. (1999) · PubMed · Cited by 31
Sparks, D. L., Beach, T. G., & Lukas, R. J. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00794-0 · Cited by 29
Depression, smoking, and nicotine: Toward a bioinformational situation by trait model
Gilbert, D. G. (1996) · Drug Development Research · doi:10.1002/(sici)1098-2299(199607/08)38:3/4 · Cited by 25
Audesirk, T., & Cabell, L. (1999) · PubMed · Cited by 25
Grenhoff, J., Janson, A. M., Svensson, T. H., & Fuxé, K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90646-d · Cited by 24
Hu, M., Bigger, C. B., & Gardner, P. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.9.4497 · Cited by 23
Neurotransmitter regulation of neuronal outgrowth, plasticity and survival in the year 2001
Kater, S. B., & Lipton, S. A. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)80025-w · Cited by 22
Nanri, T., Kasahara, N., Yamamoto, J., Miyake, H., & Watanabe, H. (1998) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.78.385 · Cited by 21
Abdulla, F. A., Calaminici, M., Wonnacott, S., Gray, J. A., Stephenson, J. D., & Sinden, J. D. (1995) · Synapse · doi:10.1002/syn.890210402 · Cited by 20
Diagnosis, treatment, and neurobiology of autism in children
Lainhart, J. E., & Piven, J. (1995) · Current Opinion in Pediatrics · doi:10.1097/00008480-199508000-00009 · Cited by 19
Nicotinic cholinergic receptors in Alzheimer’s disease
Kellar, K. J., & Wonnacott, S. (1990) · doi:10.1093/oso/9780192616142.003.0010 · Cited by 19
de la Torre, J. C., Nelson, N., Sutherland, R. J., & Pappas, B. A. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01169-4 · Cited by 18
Wevers, A., Sullivan, J. P., Giordano, T., Birtsch, C., Monteggia, L. M., Nowacki, S., Arnerić, S. P., & Schröder, H. C. (1995) · Drug Development Research · doi:10.1002/ddr.430360205 · Cited by 18
Court, J., Piggott, M., Perry, E. K., Rb, B., & Perry, R. (1992) · Newcastle University ePrints (Newcastle Univesity) · doi:10.25405/ncl.34172580 · Cited by 16
Self-citationSocci, D. J., & Arendash, G. W. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815110 · Cited by 14
Neurotransmitter regulation of neuronal outgrowth, plasticity and survival in the year 2001
Kater, S. B. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93877-z · Cited by 10
Aubert, I., Cécyre, D., Gauthier, S. G., & Quirion, R. (1995) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7445-8_47 · Cited by 5
Research works printed but not linked: 1
- Perry, 1989, Nicotine [3H-nicotine] receptor binding in human brain: characterization and involvement in cholinergic neuropathology, Neurosci. Res. Commun., 5, 117
Cited by
Sorted by citations
Levin, E. D., McClernon, F. J., & Rezvani, A. H. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0164-7 · Cited by 820
Auld, D. S., Kornecook, T. J., Bastianetto, S., & Quirion, R. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00079-5 · Cited by 678
The dynamic effects of nicotine on the developing brain
Dwyer, J. B., McQuown, S. C., & Leslie, F. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.003 · Cited by 559
Nicotinic acetylcholine receptors: From basic science to therapeutics
Hurst, R. S., Rollema, H., & Bertrand, D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.012 · Cited by 543
Belmonte, M. K., Cook, E. H., Anderson, G. M., Rubenstein, J. L. R., Greenough, W. T., Beckel-Mitchener, A., Courchesne, E., Boulanger, L. M., Powell, S. B., Levitt, P. R., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001499 · Cited by 442
Self-citation
Metadata
- Authors
- Court, J. A., Martin-Ruiz, C., Graham, A., & Perry, E.
- Affiliations
- Newcastle University (GB)
- Corresponding author
- Court, Jenny A.
- ORCID
- Martin-Ruiz, Carmen
- Venue
- Journal of Chemical Neuroanatomy
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 20
- Issue
- 3-4
- Pages
- 281-298
- ISSN
- 0891-0618 (ISSN-L)
- OpenAlex
- W1967131207
- Cited by
- 180
- References
- 186
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 4 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 1 · 2018: 9 · 2017: 2 · 2016: 6 · 2015: 8 · 2014: 5 · 2013: 6 · 2012: 8
- FWCI
- 0.69
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Journal of Chemical Neuroanatomy (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Eli Lilly and Company
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, human brain, receptor subunit expression, alpha4beta2 nAChR, alpha7 nAChR, brain development, brain aging, neurodegeneration, autism spectrum disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies
- MeSH terms
- Brain Chemistry, Brain Diseases, Humans, Receptors, Nicotinic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review